AP03000H intera 3000 hepatic artery infusion pump implantable HAI pump for use in cancer patients as standard of care therapy. The pump will be used to administer medication via catheter directly to…
Ended Purchase Order Awarded Last action
- Contract number
- 75N91025P00434
- Awardee
-
Intera Oncology Inc. UEI TNMCLD8W1RR9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,790
Award facts
- Contract value 100% obligated
- $14,790.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Newton, MA 02459, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Intera Oncology Inc., a for-profit medical device and laboratory supply company based in Newton, Massachusetts. The contract is for the purchase of Intera 3000 Hepatic Artery Infusion Pumps, which are implantable devices used to administer medication directly to the hepatic artery of cancer patients as a standard of care therapy. The contract has a ceiling value of $14,790.00 and a period of performance ending on August 8, 2025. There was no set-aside designation for this contract, indicating open market competition. The award supports the NCI's research programs, clinical trials, and patient care initiatives related to cancer treatment.
Description
AP03000H intera 3000 hepatic artery infusion pump implantable HAI pump for use in cancer patients as standard of care therapy. The pump will be used to administer medication via catheter directly to the hepatic artery.
Quick answers
Who was awarded contract 75N91025P00434?
75N91025P00434 was awarded to Intera Oncology Inc. by National Cancer Institute (National Institutes of Health) on July 8, 2025.
How much is contract 75N91025P00434 worth?
The government has obligated $14,790 on 75N91025P00434.
Was contract 75N91025P00434 competed?
The extent of competition for 75N91025P00434 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award